IL1RL2 and neoplasm: To ascertain whether IL-36–activated neutrophils modulate responses of other immune effector cells in the TME, we started by examining NK cells, which we had found to contribute to IL-36γ–driven tumor inhibition in Rag-KO animals but lack IL-36R in their naive state (Figure 4, A and C).